AT424837T - USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES

25 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims
Document	Office	Kind	Date
0015745	United Kingdom	A	2000-06-27
0015745	United Kingdom	A	2000-06-27
0015745	–	–	–
GB20000015745	–	–	–

Family members, oldest first
Document	Office	Kind
GB0015745D0	United Kingdom	D0	2000-08-16
CA2415228A1	Canada	A1	2002-01-03
WO0200227A2	World Intellectual Property Organization (WIPO)	A2	2002-01-03
AU7434101A	Australia	A	2002-01-08
US2002051822A1	United States of America	A1	2002-05-02
WO0200227A3	World Intellectual Property Organization (WIPO)	A3	2002-08-29
EP1294384A2	European Patent Office (EPO)	A2	2003-03-26
JP2004501198A	Japan	A	2004-01-15
WO0200227A8	World Intellectual Property Organization (WIPO)	A8	2004-04-15
US7078059B2	United States of America	B2	2006-07-18
FIU20060389U0	Finland	U0	2006-09-22
AU2001274341B2	Australia	B2	2006-10-19
DK200600250U1	Denmark	U1	2007-01-12
US2007048390A1	United States of America	A1	2007-03-01
DE20122679U1	Germany	U1	2007-04-05
FI7569U1	Finland	U1	2007-07-17
AT9687U1	Austria	U1	2008-02-15
DK200600250U4	Denmark	U4	2008-09-12
EP1294384B1	European Patent Office (EPO)	B1	2009-03-11
AT424837TThis record	Austria	T	2009-03-15
ATE424837T1	Austria	T1	2009-03-15
DE60137929D1	Germany	D1	2009-04-23
EP2052725A2	European Patent Office (EPO)	A2	2009-04-29
US2010015246A1	United States of America	A1	2010-01-21
CA2415228C	Canada	C	2011-09-06

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2009-09-15	Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER	RER

CPC, 10: A61P1/02
A61K33/244
Y10S424/06
A61P19/02
A61P19/08
A61P19/10
A61P29/00
A61P35/00
A61P43/00
A61P5/18
Filled: the office’s first classification
IPC, 11: A61K33 244
A61K31 28
A61K33 00
A61P1 02
A61P5 18
A61P19 02
A61P19 08
A61P19 10
A61P29 00
A61P35 00
A61P43 00

Use of lanthanum compounds for the treatment of bone diseases